Aisling A. Murphy

机构：European Medicines Agency, GlaxoSmithKline (United Kingdom) · ORCID：0000-0001-6368-9181

发表论文 10 篇 · 总被引 321 次 · h-index 7

代表论文

• Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1 (2015 · Journal of Virology · 被引 77)
• Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection (2016 · Scientific Reports · 被引 66)
• Self-disseminating vaccines for emerging infectious diseases (2015 · Expert Review of Vaccines · 被引 53)
• Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging (2013 · Virology · 被引 50)
• The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study (2022 · Frontiers in Medicine · 被引 44)
• Environmental Affordances and Children in Post-conflict Belfast (2011 · Space and Polity · 被引 15)